CDK4 and osteosarcoma: Here, we detected upregulation of CDK4 and/or CDK6 mRNA levels in all osteosarcomas, which suggests a predominant mechanism of RB-E2F pathway inactivation through RB hyperphosphorylation in this malignancy.